Client News

Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis

Mainz Biomed Enters into Technology Partnership with EDX Medical Group

DEBRA Research Announces Impact Investment into Nova Anchora to Advance Protein Therapy for Epidermolysis Bullosa

Secarna Pharmaceuticals adds leading expert to Scientific Advisory Board with appointment of Prof. Dr. Vignali

Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval

Exclusive contract for ViroCAP® My Plasma with Landsberg First Class Aesthetic opens up Viromed’s entry into the European cosmetics market

2024 Full Year Results

Viromed Medical AG welcomes Dr. Thomas Gutschlag as new Investor

Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones

Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors